Vetter News

Portfolio of early- and late-stage clinical services advances product development for injectables

02/14/2024

Our Managing Director talks with host John Shegerian about Vetter´s sustainability efforts.

02/13/2024

At the start of the year, two awards have inspired us: the Leading Employer Award and the award of being one of the 100 best family companies in…

02/05/2024

They’re one of the market’s most in-demand self-injection devices. Learn why, and what to expect if you’re planning to launch in this format.

02/01/2024

Protecting the environment is both a driving force and a challenge for Vetter as a pharmaceutical producer. In her dual studies, Lea Jochheim learns…

01/25/2024

IT meets business administration – this is how dual student Julia describes her studies at the DHBW Ravensburg and at Vetter. This is an exciting…

01/22/2024

Vetter committed to strengthening Germany as a research and production location
 

01/17/2024

Explore the role and value of a sterile injectables fill-finish CDMO, and how to find the right one to support your product.

01/16/2024

In today’s tough capital market, emerging drug developers are often under pressure to reach their first clinical milestones as quickly as possible.

01/12/2024

Watch the full interview, which covers many important developments in today's pharma and biotech industry.

01/10/2024

Great joy for Vetter: The Ravensburg Municipal Council has approved the construction of a large parking garage on the Schützenstraße site. Now the way…

01/08/2024

Learn about sterile injectables, how they’re made, and the growing role they play in supporting patient care.

12/22/2023